136 related articles for article (PubMed ID: 22392287)
1. Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States.
Erhunmwunsee L; Joshi MB; Conlon DH; Harpole DH
Cancer; 2012 Oct; 118(20):5117-23. PubMed ID: 22392287
[TBL] [Abstract][Full Text] [Related]
2. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
3. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
Johnson AM; Hines RB; Johnson JA; Bayakly AR
Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002.
Coughlin SS; King J; Richards TB; Ekwueme DU
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2154-9. PubMed ID: 17119040
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Di Maio M; Signoriello S; Morabito A; Rossi A; Maione P; Piantedosi F; Bilancia D; Cigolari S; Barbera S; Gebbia V; Daniele B; Robbiati SF; Illiano A; Ceribelli A; Carrozza F; Favaretto A; Piazza E; Piccirillo MC; Daniele G; Giordano P; Costanzo R; Sandomenico C; Rocco G; Gallo C; Perrone F; Gridelli C
Lung Cancer; 2012 Jun; 76(3):457-64. PubMed ID: 22297086
[TBL] [Abstract][Full Text] [Related]
6. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
7. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
8. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden.
Berglund A; Holmberg L; Tishelman C; Wagenius G; Eaker S; Lambe M
Thorax; 2010 Apr; 65(4):327-33. PubMed ID: 20388758
[TBL] [Abstract][Full Text] [Related]
9. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
10. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance.
Yoo HY; Thuluvath PJ
Liver Transpl; 2004 Feb; 10(2):235-43. PubMed ID: 14762861
[TBL] [Abstract][Full Text] [Related]
11. The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study.
Byers TE; Wolf HJ; Bauer KR; Bolick-Aldrich S; Chen VW; Finch JL; Fulton JP; Schymura MJ; Shen T; Van Heest S; Yin X;
Cancer; 2008 Aug; 113(3):582-91. PubMed ID: 18613122
[TBL] [Abstract][Full Text] [Related]
12. Neighborhood and individual socioeconomic determinants of hospitalization.
Taylor CB; Ahn D; Winkleby MA
Am J Prev Med; 2006 Aug; 31(2):127-34. PubMed ID: 16829329
[TBL] [Abstract][Full Text] [Related]
13. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
14. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
15. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
Milano MT; Li H; Constine LS; Travis LB
Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
[TBL] [Abstract][Full Text] [Related]
16. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
[TBL] [Abstract][Full Text] [Related]
18. Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Jun; 77(6):1926-30; discussion 1931. PubMed ID: 15172237
[TBL] [Abstract][Full Text] [Related]
19. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
20. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
Zell JA; Ou SH; Ziogas A; Anton-Culver H
Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
